The association of comorbid conditions with patient-reported outcomes in Veterans with hip and knee osteoarthritis by Zullig, Leah L. et al.
The association of comorbid conditions with patient-reported 
outcomes in Veterans with hip and knee osteoarthritis
Leah L. Zullig,
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 
Durham, NC, USA
Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC, 
USA
Hayden B. Bosworth,
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 
Durham, NC, USA
Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC, 
USA
School of Nursing, Duke University, Durham, NC, USA
Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
Amy S. Jeffreys,
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 
Durham, NC, USA
Leonor Corsino,
Division of Endocrinology, Department of Medicine, Duke University, Durham, NC, USA
Cynthia J. Coffman,
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 
Durham, NC, USA
Biostatistics and Bioinformatics, Duke University, Durham, NC, USA
Eugene Z. Oddone,
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 
Durham, NC, USA
Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC, 
USA
William S. Yancy Jr., and
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 
Durham, NC, USA
Correspondence to: Kelli D. Allen, domin004@mc.duke.edu.
Disclosures None.
U.S. Department of Veterans Affairs
Public Access Author manuscript
Clin Rheumatol. Author manuscript; available in PMC 2016 August 01.
Published in final edited form as:
















Division of General Internal Medicine, Department of Medicine, Duke University, Durham, NC, 
USA
Kelli D. Allen
Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center, 
Durham, NC, USA
Division of Rheumatology, Department of Medicine, University of North Carolina, Chapel Hill, NC, 
USA
Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, USA
Kelli D. Allen: domin004@mc.duke.edu
Abstract
There is limited understanding of how comorbid health conditions affect osteoarthritis (OA)-
related outcomes. This study examined associations of different comorbidity measures with 
baseline OA-related patient-reported outcomes (PROs) among patients with hip and knee OA. 
Data were from patients (N=300, 9 % female, mean age = 61.1; SD=9.2) enrolled in a randomized 
control trial at the Durham Veterans Affairs Medical Center. Separate multivariable regression 
models, adjusted for demographic and clinical characteristics, examined the association of each 
comorbidity measure with baseline PROs: pain, physical function, depressive symptoms, fatigue, 
and insomnia. Comorbidity measures included the Self-Administered Comorbidity Questionnaire 
(SACQ), conditions reported as activity-limiting (SACQ-AL), and indicators of depression, 
diabetes, hypertension, and back pain. Mean (SD) numbers of comorbid conditions and activity-
limiting conditions were 3.4 (1.8) and 1.6 (1.4), respectively. Comorbidity scores (SACQ overall 
and SACQ-AL) and individual comorbidity conditions were each associated with worse OA-
related PROs adjusting for demographic and clinical factors. Worse SACQ overall and SACQ-AL 
scores were associated with worse mean scores for pain, depressive symptoms, fatigue, and 
insomnia (p values <0.01). Additionally, increasing SACQ-AL scores were associated with worse 
mean scores for function (p<0.01). Depression was associated with worse pain (p=0.03), fatigue, 
and insomnia (p values <0.01). Diabetes was associated with worse fatigue (p=0.01), depressive 
symptoms (p=0.02), and insomnia (p=0.03). Back pain was associated with worse pain scores 
(p=0.02). Results provide evidence that comorbidity burden, particularly activity-limiting 
conditions, is associated with worse OA-related PROs. Interventions for patients with OA need to 
address comorbid conditions and their impact on key outcomes.
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Introduction
As a result of the increasing prevalence of osteoarthritis (OA) [1] and physical toll placed on 
individuals’ health, OA contributes significantly to societal health care costs [2–4]. To better 
understand the burden of OA, it is important to contextualize OA relative to other comorbid 
health conditions that patients may face. Comorbid conditions may exacerbate the symptoms 
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of OA (e.g., pain and physical limitations) and complicate or even compromise its 
management. This is particularly important given the high prevalence of multiple comorbid 
health conditions among individuals with OA [5–7]. For example, in a sample of Medicare 
enrollees with OA who underwent elective joint replacement surgery, Perruccio and 
colleagues identified that 68 % of patients with OA reported at least one other comorbid 
health condition, while nearly 10 % of patients reported three or more other comorbid health 
conditions [8, 9]. In a community-based cohort of patients with symptomatic knee OA, the 
average number of additional self-reported comorbid health conditions was 1.73 [10].
Although we know that comorbid conditions are common among patients with OA, little is 
known about the specific impact of comorbidities on patients’ experiences, including their 
perception of pain, function, insomnia, and depression and fatigue. For example, it is not 
known whether a cumulative number of chronic health conditions or certain specific health 
problems may have a stronger negative influence on OA-related patient-reported outcomes 
(PROs). Understanding these associations can guide clinical care by identifying aspects of 
comorbidity that have the greatest impact on OA-related PROs and therefore should be 
emphasized in treatment and care models.
Our objective was to examine associations of both global comorbidity scores and individual 
chronic conditions with baseline OA-related PROs among patients with hip and knee OA 
enrolled in an RCT. Most comorbidity scores involve a count of health conditions, some 
including weights related to risk of outcomes such as mortality or hospitalization [11, 12]. 
However, these measures typically do not consider the severity of comorbidities in terms of 
their functional impact, which is of high relevance for patients with OA who already have a 
functionally limiting condition. We used the Self-Administered Comorbidity Questionnaire, 
which allows a separate count of conditions that patients report as being “activity-limiting.” 
This is a novel aspect of this study, as we were able to differentiate between the general 
burden of comorbid conditions and that of activity-limiting conditions. In addition to global 
measures of comorbidity, we examined associations of the most common specific comorbid 
health conditions on OA-related PROs. The goal of this study was to provide a 
comprehensive evaluation of comorbidity in patients with knee and hip OA, relative to key 
PROs: pain, physical function, fatigue, insomnia, and depressive symptoms.
Methods
Study design and setting
The study uses baseline assessments from a randomized controlled trial of Patient and 
Provider Interventions for Managing Osteoarthritis in Primary Care, conducted at the 
Veterans Affairs (VA) Medical Center in Durham, NC, and its associated community-based 
outpatient clinics. Full details of the study design have been previously described [13]. In 
brief, this study used a cluster randomized controlled trial design. Thirty primary care 
providers (PCPs) were randomized to either the intervention or control group. We aimed to 
enroll ten patients (five white and five non-white) with knee and/or hip OA from each PCP. 
The provider component of the intervention involved provision of patient-specific treatment 
recommendations for OA at the point of care. The patient intervention involved 12 months 
of telephone-based support for key behavioral strategies including weight management, 
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physical activity, and cognitive behavioral pain management skills. The Institutional Review 
Board at the Durham Veterans Affairs Medical System approved this study 
(clinicaltrials.gov tracking number NCT01130740).
Participants
Eligible patients (1) were receiving care from a participating PCP, (2) had hip OA (based on 
radiographic evidence in the electronic medical record) and/or knee OA (based on 
radiographic evidence in the electronic medical record or meeting American College of 
Rheumatology clinical criteria [14]), and (3) had current symptoms in joint(s) with OA. 
Participants were overweight (body mass index (BMI) ≥25) and not meeting physical 
activity guidelines set forth by the Department of Health and Human Services [15]. These 
guidelines recommend 2 h and 30 min of moderate-intensity or 1 h and 15 min of vigorous-
intensity aerobic activity plus two or more sessions of muscle strengthening exercises. As 
previously reported [13], after an initial electronic eligibility screening, we then further 
examine the medical record to confirm the presence of an OA diagnosis and scan for 
exclusion criteria. This is followed about 1–2 weeks later by a screening telephone call to 
further assess eligibility, with particular focus on criteria that may not appear in the 
electronic medical record. Patients were excluded based on the presence of specific 
comorbid conditions, including the following: rheumatoid arthritis, fibromyalgia, or other 
systemic rheumatic disease; history of gout in knee or hip; hospitalization for a stroke, 
myocardial infarction, heart failure, or coronary artery revascularization in the past 3 
months; severe neurological conditions; Paget’s disease; dementia or other memory loss 
condition; metastatic cancer; referral for hospice or palliative care; serious psychological 
conditions; current, uncontrolled substance abuse disorder; severely impaired hearing or 
speech; and blindness.
Outcome measures
We selected the following five OA-related PROs, assessed at baseline, because of their high 
relevance to hip and knee OA: pain, physical function, depressive symptoms, fatigue, and 
insomnia. Pain and physical function limitations are hallmark symptoms of both hip and 
knee OA and common treatment targets. Both pain and physical function were measured 
with Likert-summed subscales of the Western Ontario and McMaster Universities 
Osteoarthritis Index (WOMAC) [16]. The WOMAC pain and physical function subscales 
include 5 and 17 items (ranging from 0 to 4 points each), respectively, with lower summed 
scores indicating better outcomes [17]. The WOMAC subscales are valid, sensitive 
measures for pain and function among people with OA [18].
Among people with OA, concomitant depressive symptoms occur frequently and may 
negatively impact quality of life [19]. Depressive symptoms were assessed with the Patient 
Health Questionnaire-8 (PHQ-8), a valid and reliable measure that consists of items 
corresponding to depression criteria listed in the Diagnostic and Statistics Manual Fourth 
Edition. All items are scored from 0 (not at all) to 3 (nearly every day), resulting in a 
summed score ranging from 0 to 24 [20]. Patients with OA have a notable amount of fatigue 
that can impact activity and physical function [21]. Another research suggests that fatigue 
tends to be more severe as the number of comorbid conditions increases [21]. We assessed 
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fatigue with a 10-cm visual analog scale that asked patients to indicate how severely fatigue 
had been a problem for them over the past week, using anchors of “no problem” to “major 
problem.” At least half of the patients with OA report sleep disturbances [22, 23], making 
sleep another key PRO in this group of patients. We measured global perceived insomnia 
symptoms with the Insomnia Severity Index, which includes seven items measured on 5-
point Likert scales, for a total range of 0–28.
Comorbidity measures
We examined six self-reported comorbidity measures. First, we examined the Self-
Administered Comorbidity Questionnaire (SACQ), which asks patients to indicate the 
following about each of 13 health problems and any “other” reported health problems: (1) 
whether they have the condition (yes/no), (2) whether they receive treatment for the 
condition (yes/no), and (3) whether the condition limits their activities (yes/no) [24]. 
Because all participants in this study had OA and rheumatoid arthritis was an exclusion 
condition, these two conditions were removed from the scoring of this scale in these 
analyses. This resulted in a possible score range of 0–42 (1 point each for prevalence, 
treatment, and activity limitation of 11 prespecified conditions plus three possible “other” 
conditions indicated by the participant). In the development study for the SACQ, test-retest 
reliability was 0.94 (95 % confidence interval 0.72, 0.99) as calculated by the intraclass 
correlation coefficient and 0.81 by the Spearman correlation coefficient [24]. Second, since 
we were particularly interested in activity-limiting health problems, we created a score from 
the SACQ that summed the number of conditions participants indicated as activity-limiting 
(SACQAL), again excluding the two arthritis conditions. The possible score range for this 
scale was 0–14. Third, we were interested in the individual associations of specific health 
conditions with OA-related PROs. We included the four most common self-reported 
comorbid conditions on the SACQ, each endorsed by ≥20 % of participants: depression, 
diabetes, hypertension, and back pain. These conditions have also been previously shown to 
commonly co-occur with OA [18, 19, 25, 26].
Covariates
We included the following demographic and clinical characteristics as covariates because 
each has been associated with worsened OA experience [5, 10, 18]: age (continuous), race 
(white vs. non-white, binary), gender (male vs. female, binary), marital status (married or 
living with partner vs. not married, binary), financial status (live comfortably/meet basic 
expenses vs. just meet basic expenses/do not have enough, binary), BMI (continuous), 
number of joints with arthritis symptoms (ordinal), and duration of arthritis symptoms 
(ordinal).
Statistical analyses
Since all OA-related PROs were continuous variables, multivariable linear regression 
models were used to examine the association between each combination of OA-related PRO 
and comorbidity index or specific comorbid condition. Because comorbid depression 
(independent variable) and depressive symptoms (dependent variable) measure similar 
constructs, we did not fit the model for this combination. Each multivariable model included 
one comorbidity measure and a PRO outcome, as well as the covariates described above. 
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Residual plots from models were examined to assess normality assumptions. Statistical 
significance was assessed at a conventional alpha level of ≤0.05. Data management and 
analyses were conducted in SAS version 9.2 (SAS Institute, Cary, NC).
Results
Among 1,433 patients who were approached via letter regarding study participation, 563 
were ineligible, 570 declined participation, and 300 consented and completed baseline 
assessments. Participant characteristics are shown in Table 1. Most patients were men (91 
%) since this was a sample of VA health care users. On average, patients experienced 
arthritis in six joints (SD=3.6) for a mean duration of 14 years (SD=11.6). The mean SACQ 
score was 7.2 (SD=4.1) with participants reporting means of 3.4 comorbid conditions 
(SD=1.8) and 1.6 activity-limiting conditions (SD=1.4). Very few patients reported no 
comorbid conditions (n=5, 1.8 %), 12.3 % (n=34) reported one comorbid condition, 19.6 % 
reported two comorbid conditions (n=54), 23.2 % reported three comorbid conditions 
(n=64), and 43.1 % reported four or more comorbid conditions (n=119). We were unable to 
calculate the SACQ score on 24 patients due to missing data. On the SACQ-AL, 22.5 % of 
patients reported no activity-limiting comorbid conditions (n=66), 32.3 % reported one 
activity-limiting comorbid condition (n=95), 22.8 % reported two activity-limiting comorbid 
conditions (n=67), 11.9 % reported three activity-limiting conditions (n=35), and 10.5 % 
reported four or more activity-limited comorbid conditions (n=31). The most commonly 
reported comorbid conditions were back pain (75 %), hypertension (73 %), depression (39 
%), and diabetes (38 %). The proportions of patients who reported these conditions as 
activity-limiting were as follows: back pain (63 %), hypertension (14 %), depression (26 %), 
and diabetes (16 %).
We found that comorbidity scores (SACQ overall and SACQ-AL) were associated with 
worse OA-related PROs adjusting for demographic and clinical factors (Table 2). Increasing 
(worse) overall comorbidity score (SACQ) was associated with worse mean scores (higher) 
for four PROs: pain, depressive symptoms, fatigue, and insomnia (Table 2). For example, 
each 1-point increase in mean SACQ score is associated with an estimated increase of 0.2 
point in mean WOMAC pain scores. Increasing SACQ-AL score was associated with worse 
mean scores (higher) for all PROs: pain, physical function, depressive symptoms, fatigue, 
and insomnia (Table 2). For example, each 1-point increase in mean SACQ-AL scores is 
associated with an estimated increase of 0.7 point in mean WOMAC pain scores.
We also found that individual comorbidities were associated with worse OA-related PROs 
adjusting for demographic and clinical factors (Table 2). Specifically, participants with 
comorbid depression had higher mean (worse) scores than those not having depression for 
three PROs: pain, fatigue, and insomnia. For example, participants with comorbid 
depression had an estimated 1 point higher mean WOMAC pain score than those who did 
not have depression. Participants with diabetes had higher mean (worse) scores than those 
not having diabetes for three PROs: fatigue, depressive symptoms, and insomnia. 
Participants with back pain had an estimated 1.2 point higher mean WOMAC pain score 
than those without back pain. We found no significant associations between hypertension 
and any PROs.
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For the covariates included in each model along with the comorbidity measures, in general, 
we found similar associations across models for the same PRO. Age, BMI, and duration of 
arthritis symptoms were associated with WOMAC pain in all comorbidity models. Race and 
financial status were additionally associated with WOMAC pain in models for the 
comorbidity summary scores (e.g., SACQ and SACQ-AL). Race, financial status, BMI, and 
the number of joints with arthritis symptoms were associated with WOMAC physical 
function in all comorbidity models. For the PRO depressive symptoms, age, martial status, 
financial status, and the number of joints with arthritis symptoms were associated in all 
models. Age, financial status, and BMI were generally associated with the PRO of fatigue. 
For the insomnia PRO, age and race were associated in all models; in addition, financial 
status and the number of joints with arthritis symptoms were associated in most models.
Discussion
Patients with OA often suffer from other comorbid conditions, adding to the complexity of 
their health care needs. In this study sample, patients reported an average of 3.4 additional 
comorbid conditions. Generally consistent with analyses conducted outside of the VA health 
care system [9], we found that approximately one third of patients reported one or two 
comorbid conditions and almost half reported three or more comorbid conditions. We also 
specifically evaluated self-reported activity-limiting comorbidities; patients reported an 
average of 1.6 of these conditions, with 22 % reporting three or more comorbid activity-
limiting conditions additional to OA. This high number of comorbid activity-limiting 
conditions is particularly striking since lower extremity OA itself limits activities for many 
patients. These data highlight the importance of assessing functional limitations among 
patients with hip and knee OA, not only simply related to their OA but also to comorbid 
conditions.
This study confirmed that comorbid conditions are associated with worse scores on a wide 
range of PROs relevant to lower extremity OA. Although per-unit changes in PRO scores 
were small to moderate for each unit change in comorbidity indices, many patients with OA 
have multiple comorbid conditions that cumulatively can have a substantial impact on 
PROs. It is particularly noteworthy that associations with PROs were strongest for the total 
number of activity-limiting comorbid conditions (SACQ-AL), which was significantly 
associated with all PROs: pain, decreased physical function, depressive symptoms, fatigue, 
and insomnia. These results emphasize the importance of screening for and addressing other 
severe health problems that limit patients’ activities. Physical activity and rehabilitation 
interventions can be important tools for addressing activity limitations due to both OA and 
comorbid conditions. However, these interventions are currently underutilized in patients 
with OA [27]. Our results suggest that use of these types of interventions should be 
emphasized for patients with OA and comorbid activity-limiting health problems, who are at 
greatest risk for worse PROs. In addition to associations of overall comorbidity with PROs, 
we found associations for common individual comorbid health conditions, particularly 
depression, diabetes, and back pain. Diabetes and depression were each associated with 
three PROs, confirming their impact across multiple health domains [19, 28].
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There are opportunities to make meaningful changes in the lives of patients with OA by 
recognizing patients’ comorbid conditions and enabling self-management. These study 
results emphasize that several health conditions (diabetes, depression, and back pain) appear 
to have an additional impact on health outcomes already affected by lower extremity OA 
(e.g., pain, fatigue, insomnia, and depressive symptoms). These results emphasize the 
importance of chronic care models that consider the combined impact and effective 
management strategies for these frequently co-occurring conditions. Efficiently identifying 
patients with multiple comorbid conditions has the potential to mitigate the potential 
negative impact of comorbid conditions on patients’ health and subsequently reduce health 
care utilization and cost. Such programs could intensively manage, for example, diabetes or 
depression, in parallel with OA management, or alternatively could increase the intensity 
and support of the OA-specific management in patients with comorbidities.
Our study had several limitations. Some of the associations between comorbid conditions 
and PROs may be endogenous. For example, it is uncertain whether diabetes causes patients 
to experience negative PROs such as physical limitations and depression or whether 
physical limitations and depression predispose patients to behavioral risk factors for 
diabetes. Our sample originated from a single Veterans Affairs medical center. It is possible 
that patients seeking care in the Veterans Affairs health care system have higher severity of 
illness [29] than their counterparts seeking care in the private sector. We assert that this 
limitation has minimal implications as our results are similar to those identified in non-
federal health systems [10]. The Veteran population is predominately male, as is this study 
population, yet osteoarthritis is more prevalent among females [30]. While we controlled for 
gender in statistical models, this gender difference may limit the generalizability of study 
findings. We did not obtain de novo radiographs in this pragmatic trial; although 
radiographic changes are not highly correlated with symptoms, this degree of structural 
change may certainly impact pain and other PROs, and therefore, this may be a limitation. 
Lastly, this study used patient self-report data. While patient self-report data has value 
because it is from the patients’ perspective, it is possible that patients did not accurately 
report their comorbid conditions. This is a limitation to all self-report comorbidity measures, 
and the SACQ has shown adequate associations with chart abstraction [24]. In addition, 
perceptions of whether or not a condition is activity-limiting may differ by individual.
Conclusion
Patients with OA face a multitude of comorbid conditions, such as depression, diabetes, and 
back pain, which they must manage in addition to OA. More research is needed to 
understand the intricate interplay of comorbid conditions and their impact on patients with 
OA. There is a need for clinical care models and other interventions that simultaneously 
address the complexity and interrelationships of multiple chronic health conditions in the 
context of OA.
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Table 1
Baseline patient characteristics (n=300)
Demographic characteristics N (%)
 Mean age in years (SD) 61.1 (9.2)
 Male 272 (90.7)
 Race
  White 150 (50.0)
  Non-white 150 (50.0)
 Married/living with partner 199 (66.3)
 Greater than high school education (graduate or GED) 219 (73.0)
 Employed or student 127 (42.8)
 Disabled 98 (33.0)
 Adequate financial status 197 (65.7)
Physical characteristics
 Mean body mass index (SD) 33.8 (5.8)
 Mean number of arthritic joints (SD) 6.2 (3.6)
 Mean duration of arthritis systems in years (SD) 14.2 (11.6)
Comorbid conditions
 Depression 118 (39.3)
 Diabetes 114 (38.0)
 Hypertension 219 (73.0)
 Back pain 226 (75.3)
Comorbidity summary scores
 Comorbidity summary score (SACQ) (mean (SD)) 7.2 (4.1)
 Activity-limiting summary score (SACQ-AL) (mean (SD)) 1.6 (1.4)
Patient-reported outcomes (mean (SD))
 Pain (WOMAC) 10.2 (4.0)
 Physical function (WOMAC) 33.8 (13.0)
 Depressive symptoms (PHQ-8) 6.8 (5.4)
 Fatigue (visual analog scale) 4.8 (3.2)
 Insomnia (ISI) 11.4 (8.0)
Data were missing for several variables: duration of arthritis symptoms (missing n=1), comorbid depression (n=3), hypertension (n=3), back pain 
(n=1), SACQ score (n=31), SACQ-AL score (n=6), pain (WOMAC) (n=1), physical function (WOMAC) (n=1), depressive symptoms (PHQ-8) 
(n=4), and insomnia (ISI) (n=2)
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